ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

AGLE Aeglea BioTherapeutics Inc

12,01
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Aeglea BioTherapeutics Inc AGLE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 12,01 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
12,01
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
25.4.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.4.202422:40EDGAR2Form SC 13D/A - General statement of acquisition of..
25.4.202422:21EDGAR2Form 8-K - Current report
01.4.202422:06EDGAR2Form DEF 14A - Other definitive proxy statements
20.3.202412:14EDGAR2Form PRE 14A - Other preliminary proxy statements
18.3.202421:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18.3.202413:31EDGAR2Form 8-K - Current report
14.3.202421:12EDGAR2Form POS AM - Post-Effective amendments for registration..
28.11.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202313:33EDGAR2Form 8-K - Current report
27.11.202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202322:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
27.11.202322:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
27.11.202322:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202314:30PRNUSAeglea BioTherapeutics Announces Name Change to Spyre..
23.11.202302:45EDGAR2Form 8-K - Current report
22.11.202323:00PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
15.11.202323:18EDGAR2Form S-1/A - General form for registration of securities..
15.11.202323:14EDGAR2Form 8-K - Current report
14.11.202321:13EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09.11.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:06EDGAR2Form 8-K - Current report
09.11.202322:05PRNUSAeglea BioTherapeutics Reports Third Quarter 2023 Financial..
03.11.202322:00PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
31.10.202301:00PRNUSAeglea BioTherapeutics to Participate in Upcoming November..
27.10.202303:53EDGAR2Form DEF 14A - Other definitive proxy statements
24.10.202315:00EDGAR2Form 8-K - Current report
07.10.202303:40EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
05.10.202323:13EDGAR2Form 8-K - Current report
03.10.202300:02PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
25.9.202322:02EDGAR2Form 8-K - Current report
14.9.202323:03PRNUSAeglea BioTherapeutics to Participate in Upcoming September..
08.9.202323:05EDGAR2Form 8-K - Current report
07.9.202314:40PRNUSAeglea BioTherapeutics Announces Reverse Stock Split
05.9.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202322:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.9.202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.9.202313:06EDGAR2Form 8-K - Current report
05.9.202313:00PRNUSAeglea BioTherapeutics Expands Executive Leadership Team..
11.8.202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202313:02EDGAR2Form 8-K - Current report
11.8.202313:01EDGAR2Form 8-K - Current report
11.8.202313:00PRNUSAeglea BioTherapeutics Reports Second Quarter 2023 Financial..
08.8.202303:51EDGAR2Form PRE 14A - Other preliminary proxy statements
07.8.202322:25EDGAR2Form S-3 - Registration statement under Securities Act of..
28.7.202315:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27.7.202313:01EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock